Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients
The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.
F.D.A. Experts Will Vote on a Cure for Sickle Cell Disease
The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.
A New Sickle Cell Treatment Will Change Lives — but How Many?
A new treatment for sickle cell disease will change lives — but how many?
Eyedrops From Major Brands May Cause Infection, F.D.A. Says
Target, CVS and Rite Aid are pulling products from shelves after federal investigators found unsanitary conditions and recommended a recall.
Los medicamentos cotra la obesidad tienen sobreprecio, pero esto puede cambiar
Un artículo reciente reveló que los precios netos de los nuevos fármacos para tratar la obesidad son solo una fracción de los precios de venta que se publican todos los años.
Doctor Accused of Fatally Poisoning Wife
Connor Bowman was charged with murder after investigators found that his wife, Betty Bowman, had been poisoned with a drug that Dr. Bowman had researched online.
R.S.V. Shot for Infants Is in Short Supply: What to Know
Health officials have revised their recommendations on which children should receive the new drug.
Psychedelic Mushrooms Hit the Market in Oregon
The state has pioneered a therapeutic market for psychedelic mushrooms. Researchers are watching with a mix of excitement and unease.
How Much Do Ozempic and Wegovy Cost? Not What You Think.
Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem.
10 Charged in $20 Million Scheme to Sell Black-Market H.I.V. Drugs
Federal prosecutors said the defendants encouraged low-income patients to sell their medication to them and then resold the drugs and used the money to buy luxury goods.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.